This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We will end with a discussion of how enterprises try, with mixed effects, to build protections against the loss of key personnel. and that effect, as I have noted in my earlier discussions of narrative and numbers, can be all encompassing. Who is a key person?
The first was the response that I received to my last data update , where I looked at the profitability of businesses, and specifically at how a comparison of accounting returns on equity (capital) to costs of equity (capital) can yield a measure of excess returns.
Think of restaurants, grocery stores, pharmaceutical companies. This requires more management because the risk of loss is greater, and the loss is instantaneous, and irrecoverable. In the pharmaceutical industry, drugs have a certain shelf life before they become unsafe, or their efficacy is reduced.
Even a cursory examination of the the Nifty Fifty , the stocks that drove US equities upwards in the early 1970s, reveals companies like Coca Cola and Gilette, where brand name was a significant contributor to value, as well as pharmaceutical companies like Bristol-Myers and Pfizer, which derived a large portion of their value from patents.
Shares in African eCommerce company Jumia Technologies took a dive on Monday (May 13) after Q1 losses were reported to be bigger than the year before, according to a report from Bloomberg. It also claimed that Jumia inflated its active merchant numbers and its active customer base. The company’s Q1 operating losses increased to 45.5
When scanned, the barcodes provide information about where a product was manufactured, lot numbers, authorized distributors and safe use.”. In fact, medical items and pharmaceuticals are typically the most-seized products. Just take the online marketplace industry as one example of that problem. That’s an increase of 3.3
When scanned, the barcodes provide information about where a product was manufactured, lot numbers, authorized distributors and safe use.”. In fact, medical items and pharmaceuticals are typically the most-seized products. Just take the online marketplace industry as one example of that problem. That’s an increase of 3.3
While the value crowd, bereft of victories for a long time, may be inclined to do a victory dance, it is worth noting that the same phenomenon occurred between February and March of 2020, at the start of the COVID crisis, but that growth companies quickly recouped their losses and finished ahead of mature companies by the end of 2020.
While the value crowd, bereft of victories for a long time, may be inclined to do a victory dance, it is worth noting that the same phenomenon occurred between February and March of 2020, at the start of the COVID crisis, but that growth companies quickly recouped their losses and finished ahead of mature companies by the end of 2020.
The objective of TCI is to indemnify the supplier against losses which arise as a consequence of a buyer’s inability to pay. It does not aim to replace profits lost on the transaction. Industry groups have started stockpiling vital goods, for instance non-perishable food products, pharmaceutical supplies and vaccinations.
In that paper, she posited that platform-based companies prioritized growth over profits, using their platform size to decimate competition, and that antitrust laws would have to be retooled to rein in these companies. In short, while Ms.
And because my mother and grandmother were looking at these trying to figure out what was going on, I was curious about the sea of numbers. They announced a $640 million loss and ouch. And 00:28:03 [Speaker Changed] That’s an amazing number. The visibility on earnings they grew but they stayed profitable as, as they grew.
But as a private equity owner, again, first of all, you do invest heavily of your own money in the transactions, plus you have additional ownership through, you know, the carried interest, the profits interests. I mean, those were the — that’s what got people all excited and — RITHOLTZ: That’s venture capital numbers.
I was thinking any number of things and mostly that I didn’t really know what I wanted to be when I grew up, but I was not kind of at all informed by, you know, gender norms that people asked me a lot about now, in particular how do you know a woman, how did you think about ending up in this thing? RITHOLTZ: Is that true?
And actually, interestingly, Joe was director of research there for a number of years before I moved on to start Perceptive. I’m 00:19:11 [Speaker Changed] Really intrigued by the concept at some of the big pharma, the big pharmaceutical companies and their pipeline. Lindsay Rosenwald was the founder.
As companies mature, with business models delivering profits and reinvestment needs declining, it is not surprising the companies look outward, with acquisitions often entering the equation. Thus, for foundations and perhaps even some endowment funds, investing green with as little loss in returns as possible becomes the mission statement.
Blue-collar workers in developed markets : The flip side of the rise of China and other countries as manufacturing hubs, with lower costs of operation, has been the loss of manufacturing clout and jobs for the West, with factory workers in the United States, UK and Europe bearing the brunt of the cost.
And it’s a story that is so much more than numbers. Bethany McLean: 00:10:49 [Speaker Changed] Yeah, it was fascinating, and this was highlighted or first written about in a really good New Yorker piece about what San Francisco was doing and why its numbers were so low. Profiteering fraud. No, seriously.
We organize all of the trending information in your field so you don't have to. Join 39,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content